Literature DB >> 17967879

Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity.

Anil Kumar1, Thurl E Harris, Susanna R Keller, Kin M Choi, Mark A Magnuson, John C Lawrence.   

Abstract

Rictor is an essential component of mTOR (mammalian target of rapamycin) complex 2 (mTORC2), a kinase complex that phosphorylates Akt at Ser473 upon activation of phosphatidylinositol 3-kinase (PI-3 kinase). Since little is known about the role of either rictor or mTORC2 in PI-3 kinase-mediated physiological processes in adult animals, we generated muscle-specific rictor knockout mice. Muscle from male rictor knockout mice exhibited decreased insulin-stimulated glucose uptake, and the mice showed glucose intolerance. In muscle lacking rictor, the phosphorylation of Akt at Ser473 was reduced dramatically in response to insulin. Furthermore, insulin-stimulated phosphorylation of the Akt substrate AS160 at Thr642 was reduced in rictor knockout muscle, indicating a defect in insulin signaling to stimulate glucose transport. However, the phosphorylation of Akt at Thr308 was normal and sufficient to mediate the phosphorylation of glycogen synthase kinase 3 (GSK-3). Basal glycogen synthase activity in muscle lacking rictor was increased to that of insulin-stimulated controls. Consistent with this, we observed a decrease in basal levels of phosphorylated glycogen synthase at a GSK-3/protein phosphatase 1 (PP1)-regulated site in rictor knockout muscle. This change in glycogen synthase phosphorylation was associated with an increase in the catalytic activity of glycogen-associated PP1 but not increased GSK-3 inactivation. Thus, rictor in muscle tissue contributes to glucose homeostasis by positively regulating insulin-stimulated glucose uptake and negatively regulating basal glycogen synthase activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17967879      PMCID: PMC2223287          DOI: 10.1128/MCB.01405-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.

Authors:  X Fang; S X Yu; Y Lu; R C Bast; J R Woodgett; G B Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Contraction regulation of Akt in rat skeletal muscle.

Authors:  Kei Sakamoto; Michael F Hirshman; William G Aschenbach; Laurie J Goodyear
Journal:  J Biol Chem       Date:  2002-01-23       Impact factor: 5.157

3.  An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts.

Authors:  W J Ryves; L Fryer; T Dale; A J Harwood
Journal:  Anal Biochem       Date:  1998-11-01       Impact factor: 3.365

4.  A comparison of three methods of glycogen measurement in tissues.

Authors:  J V Passonneau; V R Lauderdale
Journal:  Anal Biochem       Date:  1974-08       Impact factor: 3.365

5.  A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose.

Authors:  J A Thomas; K K Schlender; J Larner
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

6.  A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain.

Authors:  Susan Kane; Hiroyuki Sano; Simon C H Liu; John M Asara; William S Lane; Charles C Garner; Gustav E Lienhard
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

7.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

Review 8.  Glycogen and its metabolism.

Authors:  Peter J Roach
Journal:  Curr Mol Med       Date:  2002-03       Impact factor: 2.222

9.  Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

Authors:  D D Sarbassov; Siraj M Ali; Do-Hyung Kim; David A Guertin; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Curr Biol       Date:  2004-07-27       Impact factor: 10.834

10.  A protein phosphatase-1gamma1 isoform selectivity determinant in dendritic spine-associated neurabin.

Authors:  Leigh C Carmody; Patricia A Bauman; Martha A Bass; Nirmala Mavila; Anna A DePaoli-Roach; Roger J Colbran
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

View more
  104 in total

Review 1.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

2.  Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling.

Authors:  Chongben Zhang; Angela A Wendel; Matthew R Keogh; Thurl E Harris; Jie Chen; Rosalind A Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.

Authors:  Minsheng Yuan; Elizabeth Pino; Lianfeng Wu; Michael Kacergis; Alexander A Soukas
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

4.  mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.

Authors:  Stéphanie Eid; Suzan Boutary; Kawthar Braych; Ramzi Sabra; Charbel Massaad; Ahmed Hamdy; Awad Rashid; Sarah Moodad; Karen Block; Yves Gorin; Hanna E Abboud; Assaad A Eid
Journal:  Antioxid Redox Signal       Date:  2016-09-12       Impact factor: 8.401

Review 5.  Type 2 diabetes mellitus in 2013: A central role of the gut in glucose homeostasis.

Authors:  Geltrude Mingrone; Lidia Castagneto-Gissey
Journal:  Nat Rev Endocrinol       Date:  2013-12-10       Impact factor: 43.330

6.  Elevation of muscle temperature stimulates muscle glucose uptake in vivo and in vitro.

Authors:  Keiichi Koshinaka; Emi Kawamoto; Natsuki Abe; Koji Toshinai; Masamitsu Nakazato; Kentaro Kawanaka
Journal:  J Physiol Sci       Date:  2013-07-09       Impact factor: 2.781

7.  Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats.

Authors:  N Deblon; L Bourgoin; C Veyrat-Durebex; M Peyrou; M Vinciguerra; A Caillon; C Maeder; M Fournier; X Montet; F Rohner-Jeanrenaud; M Foti
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

8.  Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling.

Authors:  Deqiang Zhang; Xin Tong; Blake Arthurs; Anirvan Guha; Liangyou Rui; Avani Kamath; Ken Inoki; Lei Yin
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 9.  Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue.

Authors:  Ling Yeong Chia; Bronwyn A Evans; Saori Mukaida; Tore Bengtsson; Dana S Hutchinson; Masaaki Sato
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

Review 10.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.